Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Zoditam - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Zoditam

Approved

STANDARD

Zoditam

Ahlcon Parenterals (India) Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 0569e1555f9d5230
Company: Ahlcon Parenterals (India) Limited
Type: Standard

Approval Details

Approval Id: 0569e1555f9d5230
Drug Approval Philippines Name: Zoditam
Product Name: Zoditam
Registration Number: DRP-10530-06
Brand Name: Zoditam
Generic Name: Linezolid
Dosage Form: Solution for Injection for IV Infusion
Dosage Strength: 2mg/mL (600 mg/300 mL)
Manufacturer: Ahlcon Parenterals (India) Limited
Importer: Medinova Pharmaceutical Inc
Distributor: GA2 Pharmaceutical Inc
Issuance Date: 24 April 2024
Expiry Date: 12 October 2026
Pharmacologic Category: Antibacterial (Oxazolidinone)
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

0569e1555f9d5230

Type

Standard

Back to Philippines FDA Approvals